NewAmsterdam Pharma Ownership | Who Owns NewAmsterdam Pharma?


OverviewForecastRevenueFinancialsChart

NewAmsterdam Pharma Ownership Summary


NewAmsterdam Pharma is owned by 11.17% institutional investors, 0.96% insiders, and 87.88% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 14.81% of NAMS shares. American Funds SMALLCAP World A is the top mutual fund, with 7.93% of its assets in NewAmsterdam Pharma shares.

NAMS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNewAmsterdam Pharma11.17%0.96%87.88%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Frazier life sciences management16.94M14.81%$542.37M
Capital world investors11.11M9.71%$355.60M
Ra capital management9.55M8.35%$305.70M
Fcpm iii services b.v.9.20M8.04%$294.46M
Fmr8.77M7.66%$280.59M
Bain capital life sciences investors7.31M6.39%$233.88M
Wellington management group llp5.12M4.47%$163.76M
Deerfield management company, l.p. (series c)4.26M3.73%$136.52M
Viking global investors lp4.20M3.67%$134.56M
Duquesne family office3.07M2.68%$98.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Medicxi ventures management (jersey)2.21M42.19%$74.85M
Fcpm iii services b.v.9.20M40.77%$294.46M
Bain capital life sciences investors7.31M21.09%$233.88M
Frazier life sciences management16.94M13.96%$542.37M
Artia global partners lp503.94K3.56%$16.13M
Ra capital management9.55M3.24%$305.70M
Duquesne family office3.07M2.91%$98.28M
Healthinvest partners ab248.85K2.27%$8.43M
First turn management558.34K2.00%$17.87M
Deerfield management company, l.p. (series c)4.26M1.61%$136.52M

Top Buyers

HolderShares% AssetsChange
Fmr8.77M0.01%2.35M
Westfield capital management co lp2.20M0.30%2.20M
Capital world investors11.11M0.05%1.13M
Bnp paribas asset management957.44K0.04%780.43K
Ameriprise financial753.05K0.01%600.78K

Top Sellers

HolderShares% AssetsChange
Siren---765.71K
Jennison associates2.10M0.04%-648.12K
Capital investors1.44M0.01%-621.40K
Medicxi ventures management (jersey)2.21M42.19%-465.54K
First turn management558.34K2.00%-335.14K

New Positions

HolderShares% AssetsChangeValue
Westfield capital management co lp2.20M0.30%2.20M$70.52M
Marshall wace, llp264.80K0.01%264.80K$8.48M
Axa investment managers196.78K0.02%196.78K$5.60M
Victory capital management172.66K0.00%172.66K$5.53M
Kornitzer capital management inc /ks139.93K0.10%139.93K$4.74M

Sold Out

HolderChange
Kilter group-9.00
Advisor group-10.00
Principal securities-13.00
Coldstream capital management-24.00
Golden state equity partners-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202661-68.39%12,772,651-89.23%110.11%34-69.64%14-73.08%
Dec 31, 202555-62.07%12,251,519-89.84%100.09%32-58.44%10-72.97%
Sep 30, 202543-66.67%10,963,801-90.21%90.10%20-75.61%10-62.96%
Jun 30, 20251353.05%116,309,19516.74%1031.40%8511.84%28-9.68%
Mar 31, 2025135-3.57%111,187,22812.82%950.89%78-11.36%336.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A9.27M7.93%870.00K
Vanguard Health Care Inv3.95M3.38%280.70K
Capital Group Global Equity Canada F2.52M2.16%-
Strategic Advisers Fidelity US TtlStk2.01M1.72%14.40K
Fidelity Contrafund1.68M1.44%100.03K
Polar Capital Biotech S Inc1.63M1.40%-
Jennison SMid Cap Core Equity966.54K0.84%-119.37K
American Funds New Economy A957.48K0.82%-
Capital Group New Economy Comp957.48K0.82%-
AB Small Cap Growth A686.06K0.61%32.56K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 20, 2026Kooij Louise Frederika Chief Accounting OfficerSell$92.43K
Jul 20, 2026Kooij Louise Frederika Chief Accounting OfficerSell$990.03K
Jul 20, 2026Kooij Louise Frederika Chief Accounting OfficerSell$2.10M
Jun 22, 2026Kooij Louise Frederika Chief Accounting OfficerSell$9.22K
Jun 22, 2026Kooij Louise Frederika Chief Accounting OfficerSell$1.20M

Insider Transactions Trends


DateBuySell
2026 Q3-3
2026 Q2-3
2026 Q1-31
2025 Q4-3
2025 Q3310

NAMS Ownership FAQ


Who Owns NewAmsterdam Pharma?

NewAmsterdam Pharma shareholders are primarily institutional investors at 11.16%, followed by 0.96% insiders and 87.88% retail investors. The average institutional ownership in NewAmsterdam Pharma's industry, Biotech Stocks , is 35.43%, which NewAmsterdam Pharma falls below.

Who owns the most shares of NewAmsterdam Pharma?

NewAmsterdam Pharma’s largest shareholders are Frazier life sciences management (16.94M shares, 14.81%), Capital world investors (11.11M shares, 9.71%), and Ra capital management (9.55M shares, 8.35%). Together, they hold 32.87% of NewAmsterdam Pharma’s total shares outstanding.

Does Blackrock own NewAmsterdam Pharma?

BlackRock is not among the top 10 institutional shareholders of NewAmsterdam Pharma.

Who is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested?

Medicxi ventures management (jersey) is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested, with 42.19% of its assets in 2.21M NewAmsterdam Pharma shares, valued at 74.85M$.

Who is the top mutual fund holder of NewAmsterdam Pharma shares?

American Funds SMALLCAP World A is the top mutual fund holder of NewAmsterdam Pharma shares, with 7.93% of its total shares outstanding invested in 9.27M NewAmsterdam Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools